Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model

British Journal of Nutrition

Volumn 107, Issue 12, 2012, Pages 1793-1799

  Arseneault Bréard, Jessica ^a,b   Rondeau, Isabelle ^a,b   Gilbert, Kim ^a,b   Girard, Stéphanie Anne ^a,b   Tompkins, Thomas A ^c   Godbout, Roger ^a,b   Rousseau, Guy ^a,b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LALLEMAND SAS   (France)

Author keywords

Depression; Intestinal barrier; Myocardial infarction; Probiotics

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INTERLEUKIN 1BETA; MALTODEXTRIN; PROBIOTIC AGENT; WATER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM R0175; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; EUTHANASIA; FORCED SWIMMING TEST; HEART INFARCTION; HEART INFARCTION SIZE; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS HELVETICUS; LACTOBACILLUS HELVETICUS R0052; LEFT CORONARY ARTERY; NONHUMAN; PASSIVE AVOIDANCE; RAT; SOCIAL INTERACTION;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BIFIDOBACTERIUM; CORONARY OCCLUSION; DEPRESSION; DEXTRANS; DISEASE MODELS, ANIMAL; FLUORESCEIN-5-ISOTHIOCYANATE; INTERPERSONAL RELATIONS; INTESTINAL DISEASES; INTESTINES; LACTOBACILLUS HELVETICUS; MYOCARDIAL INFARCTION; PERMEABILITY; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING;

EID: 84862529501     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005137     Document Type: Article

References (44)

1. Guck TP, Kavan MG, Elsasser GN, et al. (2001) Assessment and treatment of depression following myocardial infarction. Am Fam Physician 64, 641-648.
2. Meneses R, Almeida MC, Abecasis J, et al. (2007) Depression in patients with myocardial infarction. Rev Port Cardiol 26, 1143-1165. (Pubitemid 351211675)
3. Bush DE, Ziegelstein RC, Tayback M, et al. (2001) Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 88, 337-341. (Pubitemid 32823291)
4. Lesperance F, Frasure-Smith N, Talajic M, et al. (2002) Fiveyear risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105, 1049-1053. (Pubitemid 34212612)
5. Frasure-Smith N, Lesperance F & Talajic M (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA 270, 1819-1825. (Pubitemid 23301435)
6. Frasure-Smith N, Lesperance F & Talajic M (1995) The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 14, 388-398.
7. Raison CL, Capuron L & Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27, 24-31. (Pubitemid 43083561)
8. Kaloustian S, Bah TM, Rondeau I, et al. (2009) Tumor necrosis factor-alpha participates in apoptosis in the limbic system after myocardial infarction. Apoptosis 14, 1308-1316.
9. Francis J, Chu Y, Johnson AK, et al. (2004) Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol 286, H2264-H2271. (Pubitemid 38685242)
10. Koo JW & Duman RS (2009) Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs 10, 664-671.
11. Wann BP, Bah TM, Boucher M, et al. (2007) Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. J Psychiatry Neurosci 32, 11-16. (Pubitemid 46276296)
12. Wann BP, Bah TM, Kaloustian S, et al. (2009) Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline. J Psychopharmacol 23, 451-459.
13. Wann BP, Boucher M, Kaloustian S, et al. (2006) Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol Psychiatry 59, 430-433. (Pubitemid 43289222)
14. Kaloustian S, Wann BP, Bah TM, et al. (2008) Apoptosis time course in the limbic system after myocardial infarction in the rat. Brain Res 1216, 87-91.
15. Kaloustian S, Wann BP, Bah TM, et al. (2007) Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala. Apoptosis 12, 1945-1951. (Pubitemid 47498230)
16. Girard SA, Bah TM, Kaloustian S, et al. (2009) Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr 102, 1420-1425.
17. Cazzola M, Tompkins TA & Matera MG (2010) Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection. Ther Adv Respir Dis 4, 259-270.
18. Wagar LE, Champagne CP, Buckley ND, et al. (2009) Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria. J Food Sci 74, M423-M430.
19. Bah TM, Benderdour M, Kaloustian S, et al. (2011) Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression. Behav Brain Res 225, 243-251.
20. Diop L, Guillou S & Durand H (2008) Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial. Nutr Res 28, 1-5.
21. Messaoudi M, Lalonde R, Violle N, et al. (2011) Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105, 755-764.
22. Wann BP, Béland SG, Rousseau G, et al. (2004) Permeability in the limbic system following myocardial infarction in the rat. In Society for Neuroscience 34th Annual Meeting, #568.4.
23. Donato KA, Gareau MG, Wang YJ, et al. (2010) Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumor necrosis factor-{alpha}-induced barrier dysfunction and proinflammatory signalling. Microbiology 156, 3288-3297.
24. Catalioto RM, Maggi CA & Giuliani S (2011) Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions. Curr Med Chem 18, 398-426.
25. Johnson-Henry KC, Hagen KE, Gordonpour M, et al. (2007) Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell Microbiol 9, 356-367. (Pubitemid 46092165)
26. Sherman PM, Johnson-Henry KC, Yeung HP, et al. (2005) Probiotics reduce enterohemorrhagic Escherichia coli O157:H7-and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 73, 5183-5188. (Pubitemid 41105678)
27. Lammers KM, Brigidi P, Vitali B, et al. (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38, 165-172. (Pubitemid 37297842)
28. Yan F & Polk DB (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277, 50959-50965. (Pubitemid 36042264)
29. Eun CS, Kim YS, Han DS, et al. (2011) Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells. APMIS 119, 49-56.
30. Fields A (2009) Discovering statistics using SPSS. In Discovering Statistics using SPSS, 3rd ed., p. 822. London: SAGE Publications Ltd.
31. Dantzer R (2001) Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15, 7-24. (Pubitemid 33070866)
32. Kent S, Bluthé RM, Kelley KW, et al. (1992) Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13, 24-28.
33. Besedovsky HO, del Rey A, Sorkin E, et al. (1986) Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233, 652-654. (Pubitemid 16011614)
34. Castanon N, Leonard BE, Neveu PJ, et al. (2002) Effects of antidepressants on cytokine production and actions. Brain Behav Immun 16, 569-574. (Pubitemid 35333736)
35. Gareau MG, Wine E, Rodrigues DM, et al. (2011) Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60, 307-317.
36. Cario E (2008) Barrier-protective function of intestinal epithelial toll-like receptor 2. Mucosal Immunol 1, Suppl. 1, S62-S66.
37. Sandek A, Bauditz J, Swidsinski A, et al. (2007) Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50, 1561-1569. (Pubitemid 47532323)
38. Yirmiya R, Pollak Y, Morag M, et al. (2000) Illness, cytokines, and depression. Ann N Y Acad Sci USA 917, 478-487.
39. Bruewer M, Luegering A, Kucharzik T, et al. (2003) Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171, 6164-6172. (Pubitemid 37467239)
40. Cario E, Gerken G & Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359-1374. (Pubitemid 46627595)
41. Karczewski J, Troost FJ, Konings I, et al. (2010) Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 298, G851-G859.
42. Heijtz RD, Wang S, Anuar F, et al. (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108, 3047-3052.
43. Gareau MG, Jury J, MacQueen G, et al. (2007) Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 56, 1522-1528. (Pubitemid 350033189)
44. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11, 47-60. (Pubitemid 14088970)